Reported Earnings • May 17
Full year 2026 earnings released: EPS: ₹10.96 (vs ₹8.63 in FY 2025) Full year 2026 results: EPS: ₹10.96 (up from ₹8.63 in FY 2025). Revenue: ₹5.83b (up 35% from FY 2025). Net income: ₹273.3m (up 27% from FY 2025). Profit margin: 4.7% (down from 5.0% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Announcement • May 15
DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 11, 2026 DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 11, 2026. Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹320, the stock trades at a trailing P/E ratio of 30.6x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 16% over the past three years. Announcement • May 07
DMCC Speciality Chemicals Limited to Report Q4, 2026 Results on May 15, 2026 DMCC Speciality Chemicals Limited announced that they will report Q4, 2026 results on May 15, 2026 New Risk • Apr 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.4% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹5.58b market cap, or US$59.8m). Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ₹269, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 3.4% over the past three years. Reported Earnings • Feb 07
Third quarter 2026 earnings released: EPS: ₹2.47 (vs ₹3.16 in 3Q 2025) Third quarter 2026 results: EPS: ₹2.47 (down from ₹3.16 in 3Q 2025). Revenue: ₹1.51b (up 28% from 3Q 2025). Net income: ₹61.7m (down 22% from 3Q 2025). Profit margin: 4.1% (down from 6.7% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Jan 29
DMCC Speciality Chemicals Limited to Report Q3, 2026 Results on Feb 06, 2026 DMCC Speciality Chemicals Limited announced that they will report Q3, 2026 results on Feb 06, 2026 Announcement • Jan 12
DMCC Speciality Chemicals LimitedAppoints Pallavi Pednekar As Company Secretary & Compliance Officer, Effective January 27, 2026 The board of directors of DMCC Speciality Chemicals Limited at its meeting held on January 10, 2026, appointed Ms. Pallavi Pednekar as Company Secretary & Compliance Officer and Key Managerial Personnel of the Company, with effect from January 27, 2026. Ms. Pallavi Pednekar holds a Bachelor's degree in Commerce, an LLB, and is a Qualified Company Secretary (ACS 33498). She has over 12 years of experience in secretarial and legal function, across various companies. She has served as Company Secretary at NGL Fine-Chem Limited and has also worked with Survival Technologies Private Limited. Reported Earnings • Nov 16
Second quarter 2026 earnings released: EPS: ₹2.31 (vs ₹2.33 in 2Q 2025) Second quarter 2026 results: EPS: ₹2.31 (down from ₹2.33 in 2Q 2025). Revenue: ₹1.26b (up 23% from 2Q 2025). Net income: ₹57.5m (down 1.1% from 2Q 2025). Profit margin: 4.6% (down from 5.7% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • Nov 03
DMCC Speciality Chemicals Limited to Report Q2, 2026 Results on Nov 11, 2025 DMCC Speciality Chemicals Limited announced that they will report Q2, 2026 results on Nov 11, 2025 Board Change • Oct 21
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-Executive Independent Director Haren Parekh was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Oct 20
DMCC Speciality Chemicals Limited Announces Resignation of Dr. (Mrs.) Janaki Ashwin Patwardhan as Non-Executive Independent Woman Director and from All Committees, Effective from October 17, 2025 DMCC Speciality Chemicals Limited announced that Dr. (Mrs.) Janaki Ashwin Patwardhan, has resigned from the position of Non-Executive Independent Woman Director of the Company to explore other options. Consequent to this resignation she informed her disinclination to continue for second term for which members approval was obtained. Consequently, Dr. (Mrs.) Janaki Ashwin Patwardhan shall also cease to be a member of the Corporate Social Responsibility Committee, Risk Management Committee and Independent Director's Committee. Date of cessation is October 17, 2025. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Xchanging Solutions Limited - Non-Executive Independent Director, Audit Committee - Member, Stakeholders' Relationship Committee - Chairperson, Corporate Social Responsibility Committee - Chairperson, Nomination and Remuneration Committee - Member Dr. (Mrs.) Janaki Ashwin Patwardhan had confirmed that there are no material reasons for her resignation other than those mentioned in his resignation letter. New Risk • Oct 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Market cap is less than US$100m (₹7.68b market cap, or US$86.5m). Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹343, the stock trades at a trailing P/E ratio of 30.6x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 9.3% over the past three years. Declared Dividend • Aug 11
Dividend increased to ₹2.50 Dividend of ₹2.50 is 150% higher than last year. Ex-date: 22nd August 2025 Payment date: 10th October 2025 Dividend yield will be 0.7%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 26% per year over the past 7 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 68% to shift the payout ratio to a potentially unsustainable range, which is more than the 1.1% EPS decline seen over the last 5 years. Announcement • Aug 09
DMCC Speciality Chemicals Limited announces Annual dividend, payable on October 10, 2025 DMCC Speciality Chemicals Limited announced Annual dividend of INR 2.5000 per share payable on October 10, 2025, ex-date on August 22, 2025 and record date on August 22, 2025. Reported Earnings • Aug 08
First quarter 2026 earnings released: EPS: ₹3.11 (vs ₹0.55 in 1Q 2025) First quarter 2026 results: EPS: ₹3.11 (up from ₹0.55 in 1Q 2025). Revenue: ₹1.27b (up 49% from 1Q 2025). Net income: ₹77.6m (up 466% from 1Q 2025). Profit margin: 6.1% (up from 1.6% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Jul 30
DMCC Speciality Chemicals Limited to Report Q1, 2026 Results on Aug 07, 2025 DMCC Speciality Chemicals Limited announced that they will report Q1, 2026 results on Aug 07, 2025 Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹318, the stock trades at a trailing P/E ratio of 37x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years. New Risk • Jun 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₹6.86b market cap, or US$80.2m). Reported Earnings • May 07
Full year 2025 earnings released: EPS: ₹8.63 (vs ₹4.65 in FY 2024) Full year 2025 results: EPS: ₹8.63 (up from ₹4.65 in FY 2024). Revenue: ₹4.33b (up 32% from FY 2024). Net income: ₹215.3m (up 86% from FY 2024). Profit margin: 5.0% (up from 3.5% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • May 05
DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 10, 2025 DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 10, 2025. Announcement • Apr 25
DMCC Speciality Chemicals Limited to Report Q4, 2025 Results on May 05, 2025 DMCC Speciality Chemicals Limited announced that they will report Q4, 2025 results on May 05, 2025 Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹254, the stock trades at a trailing P/E ratio of 30.6x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 42% over the past three years. Reported Earnings • Feb 14
Third quarter 2025 earnings released: EPS: ₹3.16 (vs ₹0.12 in 3Q 2024) Third quarter 2025 results: EPS: ₹3.16 (up from ₹0.12 in 3Q 2024). Revenue: ₹1.18b (up 47% from 3Q 2024). Net income: ₹78.7m (up ₹75.6m from 3Q 2024). Profit margin: 6.7% (up from 0.4% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Announcement • Feb 04
DMCC Speciality Chemicals Limited to Report Q3, 2025 Results on Feb 12, 2025 DMCC Speciality Chemicals Limited announced that they will report Q3, 2025 results on Feb 12, 2025 Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹311, the stock trades at a trailing P/E ratio of 60.4x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 19% over the past three years. New Risk • Jan 11
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.60b (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 31% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₹8.60b market cap, or US$99.8m). New Risk • Dec 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 31% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.6% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Dec 03
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹373, the stock trades at a trailing P/E ratio of 70.5x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 18% over the past three years. Reported Earnings • Oct 29
Second quarter 2025 earnings released: EPS: ₹2.33 (vs ₹0.95 in 2Q 2024) Second quarter 2025 results: EPS: ₹2.33 (up from ₹0.95 in 2Q 2024). Revenue: ₹1.03b (up 35% from 2Q 2024). Net income: ₹58.1m (up 145% from 2Q 2024). Profit margin: 5.6% (up from 3.1% in 2Q 2024). Announcement • Oct 16
DMCC Speciality Chemicals Limited to Report Q2, 2025 Results on Oct 28, 2024 DMCC Speciality Chemicals Limited announced that they will report Q2, 2025 results on Oct 28, 2024 Announcement • Sep 16
DMCC Speciality Chemicals Limited Announces Cessation of Madhu Thakorlal Ankelshwaria as an Independent Director DMCC Speciality Chemicals Limited announced that Shri Madhu Thakorlal Ankelshwaria has completed his second consecutive term as an Independent Director on September 16, 2024 and consequently cease to be a Director of the Company with effect from the closing of Business hours on September 16, 2024. The Board of Directors and Management of the Company extend their sincere appreciation for the valuable contribution made by Shri Madhu Thakorlal Ankleshwaria as an Independent Director with the Company. Upcoming Dividend • Aug 21
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 28 August 2024. Payment date: 04 October 2024. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.6%). Reported Earnings • Aug 13
Full year 2024 earnings released: EPS: ₹4.65 (vs ₹2.78 in FY 2023) Full year 2024 results: EPS: ₹4.65 (up from ₹2.78 in FY 2023). Revenue: ₹3.28b (down 15% from FY 2023). Net income: ₹115.9m (up 67% from FY 2023). Profit margin: 3.5% (up from 1.8% in FY 2023). Announcement • Jul 26
DMCC Speciality Chemicals Limited to Report Q1, 2025 Results on Aug 13, 2024 DMCC Speciality Chemicals Limited announced that they will report Q1, 2025 results on Aug 13, 2024 Announcement • Jul 25
DMCC Speciality Chemicals Limited Announces Resignation of Omkar Chandrakant Mhamunkar as Company Secretary & Compliance Officer, Effective July 29, 2024 DMCC Speciality Chemicals Limited announced that Mr. Omkar Chandrakant Mhamunkar has resigned from the position of company secretary & compliance officer of the company to explore opportunities outside the organization. Mr. Omkar Chandrakant Mhamunkar will continue to discharge his duties as company secretary & compliance officer of the company until the close of Business hours on July 29, 2024. Further, simultaneous to the resignation of Mr. Omkar Chandrakant Mhamunkar, he will also cease to be Key Managerial Personnel under the provisions of Section 203 and other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI LODR Regulations for determining the materiality of any event or transaction for making the required disclosures to the Stock Exchange with effect from close of business hours of July 29, 2024. Board Change • May 29
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. Non-Executive Independent Director Janaki Patwardhan was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • May 25
DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 04, 2024 DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 04, 2024. Reported Earnings • May 24
Full year 2024 earnings released: EPS: ₹4.65 (vs ₹2.78 in FY 2023) Full year 2024 results: EPS: ₹4.65 (up from ₹2.78 in FY 2023). Revenue: ₹3.38b (down 12% from FY 2023). Net income: ₹115.9m (up 67% from FY 2023). Profit margin: 3.4% (up from 1.8% in FY 2023). The increase in margin was driven by lower expenses. Announcement • May 24
DMCC Speciality Chemicals Limited Appoints Dilip Trimbak Gokhale as Sr. Executive Vice-President Based on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of the DMCC Speciality Chemicals Limitedat its meeting held on 23rd May, 2024 considered and approved the appointment of Shri Dilip Trimbak Gokhale, as a Senior Management Personnel of the Company designated as Sr. Executive Vice-President for the period of Three (3) consecutive years with effect from May 23, 2024 to May 22, 2027. Shri Dilip Trimbak Gokhale is a Commerce and law graduate and fellow member of the Institute of Company Secretaries of India. He is also member of All India Management Association holding a Post-Graduation Diploma in Management from the said institute. He is also a certified associate of the Indian Institute of Bankers, Mumbai and is an Ex-Banker. Shri Dilip Trimbak Gokhale has been associated with the Company for over 35 years and has been handling various diversified activities and matters of the Company for a long, like Secretarial, legal, Corporate Governance, HR & Administration, Insurance, Banking and Internal Audit etc. The Company vide its letter dated May 21, 2024, informed the stock exchange about the completion of three (3) year term of Shri Dilip Trimbak Gokhale, (DIN: 06734397) as an Executive Director of the Company with effect from May 21, 2024 and upon completion of his term he also ceased to be a Director of the Company. The Stock exchanges were informed that considering his vast experience of around 35+ years and long association with the Company, he will continue to be associated with the Company. Announcement • May 18
DMCC Speciality Chemicals Limited to Report Q4, 2024 Results on May 23, 2024 DMCC Speciality Chemicals Limited announced that they will report Q4, 2024 results on May 23, 2024 Valuation Update With 7 Day Price Move • Apr 05
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹326, the stock trades at a trailing P/E ratio of 64.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 32% over the past year. Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: ₹0.12 (vs ₹1.27 loss in 3Q 2023) Third quarter 2024 results: EPS: ₹0.12 (up from ₹1.27 loss in 3Q 2023). Revenue: ₹812.4m (up 13% from 3Q 2023). Net income: ₹3.07m (up ₹34.7m from 3Q 2023). Profit margin: 0.4% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Announcement • Feb 01
DMCC Speciality Chemicals Limited to Report Q3, 2024 Results on Feb 09, 2024 DMCC Speciality Chemicals Limited announced that they will report Q3, 2024 results on Feb 09, 2024 Reported Earnings • Nov 13
Second quarter 2024 earnings released: EPS: ₹0.95 (vs ₹1.13 loss in 2Q 2023) Second quarter 2024 results: EPS: ₹0.95 (up from ₹1.13 loss in 2Q 2023). Revenue: ₹765.2m (down 27% from 2Q 2023). Net income: ₹23.7m (up ₹52.0m from 2Q 2023). Profit margin: 3.1% (up from net loss in 2Q 2023). The move to profitability was driven by lower expenses. Announcement • Nov 01
DMCC Speciality Chemicals Limited to Report Q2, 2024 Results on Nov 08, 2023 DMCC Speciality Chemicals Limited announced that they will report Q2, 2024 results on Nov 08, 2023 Announcement • Aug 10
DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 12, 2023 DMCC Speciality Chemicals Limited, Annual General Meeting, Sep 12, 2023. Reported Earnings • Aug 10
First quarter 2024 earnings released: EPS: ₹1.26 (vs ₹2.50 in 1Q 2023) First quarter 2024 results: EPS: ₹1.26 (down from ₹2.50 in 1Q 2023). Revenue: ₹865.1m (down 24% from 1Q 2023). Net income: ₹31.4m (down 50% from 1Q 2023). Profit margin: 3.6% (down from 5.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Announcement • Aug 03
DMCC Speciality Chemicals Limited to Report Q1, 2024 Results on Aug 09, 2023 DMCC Speciality Chemicals Limited announced that they will report Q1, 2024 results on Aug 09, 2023 Announcement • May 19
DMCC Speciality Chemicals Limited Appoints Sunil Kumar Goyal as Chief Finance Officer DMCC Speciality Chemicals Limited announced the Appointment of Shri Sunil Kumar Goyal, as Chief Finance Officer and Key Managerial Personnel of the Company in terms of Section 203 of the Companies Act 2013 - with effect from May 18, 2023. Shri Sunil Kumar Goyal is a member of the Institute of Chartered Accountants of India, Institute of Company Secretaries of India, and holds a degree in Bachelor of Business Administration (BBA). He has a professional experience of more than 14 years in areas like Corporate Finance, Corporate Accounting, Project Finance, Treasury, Forex, Banking, Taxation, Audits and other allied areas and is familiar with Computerised System of Accounting (ERP Solutions) such as SAP HANA, SAP B1, Tally. Reported Earnings • May 19
Full year 2023 earnings released: EPS: ₹2.78 (vs ₹8.56 in FY 2022) Full year 2023 results: EPS: ₹2.78 (down from ₹8.56 in FY 2022). Revenue: ₹3.90b (up 19% from FY 2022). Net income: ₹69.3m (down 68% from FY 2022). Profit margin: 1.8% (down from 6.5% in FY 2022). The decrease in margin was driven by higher expenses. Announcement • May 11
DMCC Speciality Chemicals Limited to Report Q4, 2023 Results on May 17, 2023 DMCC Speciality Chemicals Limited announced that they will report Q4, 2023 results on May 17, 2023 Reported Earnings • Feb 12
Third quarter 2023 earnings released: ₹1.27 loss per share (vs ₹2.58 profit in 3Q 2022) Third quarter 2023 results: ₹1.27 loss per share (down from ₹2.58 profit in 3Q 2022). Revenue: ₹720.4m (down 12% from 3Q 2022). Net loss: ₹31.6m (down 149% from profit in 3Q 2022). Announcement • Feb 11
DMCC Speciality Chemicals Limited Announces Resignation of Chirag Jawant Shah as Chief Financial Officer DMCC Speciality Chemicals Limited announced that Mr. Chirag Jawant Shah has resigned from the office of Chief Finance Officer of the Company for the better prospects and he ceased to be Chief Finance Officer from the closingof 10th February, 2023. Announcement • Feb 01
DMCC Speciality Chemicals Limited to Report Q3, 2023 Results on Feb 10, 2023 DMCC Speciality Chemicals Limited announced that they will report Q3, 2023 results on Feb 10, 2023 Recent Insider Transactions • Nov 26
MD, CEO & Executive Director recently sold ₹2.8m worth of stock On the 24th of November, Bimal Goculdas sold around 9k shares on-market at roughly ₹299 per share. This transaction amounted to 2.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Bimal's only on-market trade for the last 12 months. Reported Earnings • Nov 09
Second quarter 2023 earnings released: ₹1.13 loss per share (vs ₹1.47 profit in 2Q 2022) Second quarter 2023 results: ₹1.13 loss per share (down from ₹1.47 profit in 2Q 2022). Revenue: ₹1.05b (up 45% from 2Q 2022). Net loss: ₹28.3m (down 177% from profit in 2Q 2022). Reported Earnings • Aug 14
First quarter 2023 earnings released: EPS: ₹2.50 (vs ₹3.01 in 1Q 2022) First quarter 2023 results: EPS: ₹2.50 (down from ₹3.01 in 1Q 2022). Revenue: ₹1.14b (up 62% from 1Q 2022). Net income: ₹62.3m (down 17% from 1Q 2022). Profit margin: 5.5% (down from 11% in 1Q 2022). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improved over the past week After last week's 18% share price gain to ₹379, the stock trades at a trailing P/E ratio of 38.6x. Average trailing P/E is 17x in the Chemicals industry in India. Reported Earnings • May 25
Full year 2022 earnings released: EPS: ₹8.56 (vs ₹13.06 in FY 2021) Full year 2022 results: EPS: ₹8.56 (down from ₹13.06 in FY 2021). Revenue: ₹3.32b (up 66% from FY 2021). Net income: ₹213.4m (down 35% from FY 2021). Profit margin: 6.4% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • May 11
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹346, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 18x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improved over the past week After last week's 19% share price gain to ₹449, the stock trades at a trailing P/E ratio of 39.4x. Average trailing P/E is 20x in the Chemicals industry in India. Reported Earnings • Feb 13
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹2.58 (up from ₹1.89 in 3Q 2021). Revenue: ₹817.4m (up 73% from 3Q 2021). Net income: ₹64.4m (up 37% from 3Q 2021). Profit margin: 7.9% (down from 10.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. 
